ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands, with an office in Cambridge, Massachusetts, USA, developing innovative RNA-editing medicines through its proprietary Axiomer platform. Our mission is to edit RNA, treat disease
Radboud University Medical Center UI Institute seeks a PhD researcher to develop AI-driven protein engineering approaches for targeting retinal diseases. Solliciteer nu, lees de vacaturedetails door naar beneden te scrollen. Controleer of u over de nodige
Job description Heeft u wat nodig is om te slagen? De volgende informatie dient door alle kandidaten zorgvuldig gelezen te worden. Inherited retinal diseases are an important causes of blindness. Currently, various types of genetic therapy
Professional | Permanent | Full-time | Hybrid Klaar om te solliciteren? Voordat u dat doet, zorg ervoor dat u alle details met betrekking tot deze baan in de onderstaande omschrijving leest. If you’re passionate about changing
ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands with an office in and Cambridge, Massachusetts, USA. Als de volgende functie-eisen en ervaring overeenkomen met uw vaardigheden, zorg er dan voor dat u
ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands with an office in Cambridge, Massachusetts, USA. At ProQR, we are on a mission to edit RNA, treat disease and change lives. A team